TNSN05074A1 - SUBSTITUTED HETEROCYCLIC PIPERAZINES FOR THE TREATMENT OF SCHIZOPHRENIA - Google Patents

SUBSTITUTED HETEROCYCLIC PIPERAZINES FOR THE TREATMENT OF SCHIZOPHRENIA

Info

Publication number
TNSN05074A1
TNSN05074A1 TNP2005000074A TNSN05074A TNSN05074A1 TN SN05074 A1 TNSN05074 A1 TN SN05074A1 TN P2005000074 A TNP2005000074 A TN P2005000074A TN SN05074 A TNSN05074 A TN SN05074A TN SN05074 A1 TNSN05074 A1 TN SN05074A1
Authority
TN
Tunisia
Prior art keywords
treatment
schizophrenia
substituted heterocyclic
piperazines
heterocyclic piperazines
Prior art date
Application number
TNP2005000074A
Other languages
French (fr)
Inventor
Tonja Lynn Andreana
Stephen Sung Yong Cho
James Michael Graham
Tracy Fay Gregory
Jr Harry Ralph Howard
Brian Edward Kornberg
Sham Shridhar Nikam
Derek Andrew Pflum
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2003/003902 external-priority patent/WO2004026864A1/en
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of TNSN05074A1 publication Critical patent/TNSN05074A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENTION CONCERNE DES COMPOSES DE FORMULE 1, DANS LAQUELLE X, Y, Z, A, R1, R2, R3, R4, R9, W1 ET W2 SONT TELS QUE DEFINIS DANS LE PRESENT MEMOIRE , DES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET LEUR UTILISATION DANS LE TRAITEMENT DE TROUBLES DU SYSTEME NERVEUX CENTRAL ET D'AUTRES AFFECTIONS.The present invention relates to compounds of Formula 1 in which X, Y, Z, A, R 1, R 2, R 3, R 4, R 9, W 1 and W 2 are as defined herein, pharmaceutical compositions containing them and their use. IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS AND OTHER DISORDERS.

TNP2005000074A 2002-09-17 2005-03-17 SUBSTITUTED HETEROCYCLIC PIPERAZINES FOR THE TREATMENT OF SCHIZOPHRENIA TNSN05074A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41147502P 2002-09-17 2002-09-17
PCT/IB2003/003902 WO2004026864A1 (en) 2002-09-17 2003-09-05 Heterocyclic substituted piperazines for the treatment of schizophrenia

Publications (1)

Publication Number Publication Date
TNSN05074A1 true TNSN05074A1 (en) 2007-05-14

Family

ID=35476681

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2005000074A TNSN05074A1 (en) 2002-09-17 2005-03-17 SUBSTITUTED HETEROCYCLIC PIPERAZINES FOR THE TREATMENT OF SCHIZOPHRENIA

Country Status (4)

Country Link
CN (1) CN1701072A (en)
CR (1) CR7735A (en)
TN (1) TNSN05074A1 (en)
ZA (1) ZA200502216B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010012121A1 (en) * 2008-07-28 2010-02-04 江苏国华投资有限公司 Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia
BRPI0918949A2 (en) * 2008-09-22 2019-09-24 Hoffmann La Roche 5-ht2a and piperazine d3 receptor modulators
CN102718758A (en) * 2011-03-31 2012-10-10 江苏恒谊药业有限公司 Quinolinone derivative and application thereof as anti-schizophrenic drug
CN103130737B (en) * 2011-12-05 2015-12-02 江苏恒谊药业有限公司 Hexanaphthene aminated compounds and the application as antipsychotic drug thereof
CN113727968B (en) * 2019-05-14 2024-08-23 杏林制药株式会社 Process for preparing 4-oxo-pyrrolidine-3-carboxamide derivatives
CN112142737B (en) * 2019-06-29 2022-03-18 武汉珈瑜科技有限公司 Solid form of hydrochloride of medicine for treating schizophrenia

Also Published As

Publication number Publication date
CR7735A (en) 2005-06-15
CN1701072A (en) 2005-11-23
ZA200502216B (en) 2005-09-26

Similar Documents

Publication Publication Date Title
MA27438A1 (en) SUBSTITUTED HETEROCYCLIC PIPERAZINES FOR THE TREATMENT OF SCHIZOPHRENIA
MA31373B1 (en) Harmonic periodic amine compound.
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
MA28094A1 (en) Bicyclic derivatives [3.1.0] as glycine transporter inhibitors
MA27568A1 (en) PYRROLOPYRIMIDINE DERIVATIVES
TNSN05104A1 (en) THIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
MA27774A1 (en) PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
TNSN04246A1 (en) BENZOCONDENSIC HETEROARYLAMIDE DERIVATIVES OF THIENOPYRIDINES USEFUL AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND METHODS FOR THEIR USE
TNSN03130A1 (en) HIV PROTEASE INHIBITORS, COMPOSITIONS CONTAINING THEM, PHARMACEUTICAL USES THEREOF AND MATERIALS FOR THEIR SYNTHESIS
TNSN98154A1 (en) NOVEL 2-AMINOPYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN99156A1 (en) NOVEL HYDROXYPIPECOLATE-HYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA29429B1 (en) SUBSTITUTED ARYLAMINE COMPOUNDS AND THEIR USE AS MODULATORS OF 5-HT6
TNSN04156A1 (en) SUBSTITUTED PYRIDINONES AS MODULATORS OF MAP-KINASE P38
TN2010000175A1 (en) SUBSTITUTED PIPERIDINO-DIHYDROTHIENOPYRIMIDINES
MA26875A1 (en) AZAPOLYCYCLIC COMPOUNDS WITH CONDENSED ARYL CORE
TNSN98035A1 (en) ATROPISOMERS OF 3-ARYL-4 (3H) -QUINAZOLINONES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
TNSN08445A1 (en) TRIAZOLOPYRAZINE DERIVATIVES USEFUL AS ANTICANCER AGENT
TNSN07380A1 (en) [3.1.0] BICYCLIC HETEROARYLAMIDES AS TRANSPORT INHIBITORS OF GLYCIN TYPE 1
TNSN05073A1 (en) NOVEL SPIROCONDENSE QUINAZOLINONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
MA30696B1 (en) (3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL) -ACETIC DERIVATIVES
MA33053B1 (en) INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE (PARP)
MA27887A1 (en) SUBSTITUTED DICETOPIPERAZINES AND THEIR USE AS ANTAGONISTS OF OCYTOCIN
MA30089B1 (en) (Arylsulfonyl) -PYRASOLOPIPERIDINES
TNSN05074A1 (en) SUBSTITUTED HETEROCYCLIC PIPERAZINES FOR THE TREATMENT OF SCHIZOPHRENIA
TNSN99155A1 (en) 1-ARYL-3-ARYLMETHYL-1,8-NAPHTYRIDINE-4 (1H) -ONES NOVELS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM